Research Update on the Phenotype of Cardiovascular Diseases Associated With Antiphospholipid Syndrome
10.3969/j.issn.1000-3614.2024.03.016
- VernacularTitle:抗磷脂综合征相关心血管疾病的表现及新进展
- Author:
Zixin CHEN
1
;
Buxilite DA
;
Zhou ZHOU
;
Yang ZHANG
Author Information
1. 中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院 实验诊断中心,北京 100037
- Keywords:
antiphospholipid syndrome;
antiphospholipid antibody;
cardiovascular disease;
thrombosis
- From:
Chinese Circulation Journal
2024;39(3):306-312
- CountryChina
- Language:Chinese
-
Abstract:
Antiphospholipid syndrome is a systemic autoimmune disease characterized by recurrent thrombotic events,pregnancy complications and persistent positive antiphospholipid antibodies.As a systemic disease,antiphospholipid syndrome can affect multiple organs and systems,including the cardiovascular system.Antiphospholipid syndrome-related cardiovascular diseases can cause serious threats to patients'lives.In the updated ACR/EULRA classification criteria for antiphospholipid syndrome issued in 2023,valvular disease has been included in the clinical criteria of antiphospholipid syndrome,which highlights the importance of considering cardiovascular diseases associated with antiphospholipid syndrome.This article reviews the research progress on the phenotype and mechanisms of cardiovascular diseases associated with antiphospholipid syndrome.
